Lifecore Biomedical LFCR
NASDAQ LFCR
$4.52 +0.06 (+1.35%)
At close: Aug 20, 2026 · 4:00 PM EDT

Lifecore Biomedical, Inc. \De\ (LFCR) Debt Ratio (2011 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly Debt Ratio of 0.54 for Q2 2025, up 10.33% year-over-year from 0.49 in Q2 2024, and up 3.68% quarter-over-quarter from 0.53 in Q1 2025.

Lifecore Biomedical, Inc. \De\ (LFCR) Debt Ratio (2011 - 2025) Analysis & Trends

Lifecore Biomedical, Inc. \De\'s Debt Ratio history runs 15 years deep, the most recent figure standing at 0.54 for Q2 2025.

  • In Q2 2025, Debt Ratio rose 10.33% year-over-year to 0.54; the TTM figure through May 2025 stood at 0.54 (up 10.33% YoY), while the FY2025 annual figure was 0.54, up 10.33% from the prior year.
  • Debt Ratio for Q2 2025 stood at 0.54, up from 0.53 in the prior quarter.
  • The five-year high for Debt Ratio was 0.89 in Q4 2022, with the low at 0.07 in Q2 2023.
  • The 5-year median for Debt Ratio is 0.39 (2021), against an average of 0.38.
  • The sharpest annual moves came in 2023 and 2024: Debt Ratio plunged 86.37% in 2023, then jumped 620.2% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Debt Ratio stood at 0.39 in 2021, then jumped by 125.93% to 0.89 in 2022, then plunged by 57.61% to 0.38 in 2023, then climbed by 15.37% to 0.44 in 2024, then gained by 25.05% to 0.54 in 2025.
  • Business Quant data shows LFCR's Debt Ratio at 0.54 in Q2 2025, 0.53 in Q1 2025, and 0.44 in Q4 2024.

Peer Comparison

Historic Data

Download Data
DateValue
May 25, 2025 0.54
Feb 23, 2025 0.53
Nov 24, 2024 0.44
Aug 25, 2024 0.09
May 26, 2024 0.49
Feb 25, 2024 0.08
Nov 26, 2023 0.38
Aug 27, 2023 0.08
May 28, 2023 0.07
Feb 26, 2023 0.42
Nov 27, 2022 0.89
Aug 28, 2022 0.54
May 29, 2022 0.50
Feb 27, 2022 0.37
Nov 28, 2021 0.39
Aug 29, 2021 0.35
May 30, 2021 0.39
Feb 28, 2021 0.37
Nov 29, 2020 0.19
Aug 30, 2020 0.32